ALSTON & BIRD LLP for KERECIS
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
General health care issues related to Medicare coverage policies. FY2027 Appropriations Bill.
Foreign entity interest: To the extent that Kerecis realizes any benefit from legislative or executive action, so, too, would its parent company, Coloplast A/S.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURA FRIEDEL | — |
| JONATHAN JAGODA | — |
| Y. BRIAN LEE | — |
| JAMES PATRICK PALUSKIEWICZ | — |
| MARK RAYDER | — |
Health Issues HCR
General health care issues related to Medicare coverage policies. FY2027 Appropriations Bill.
Foreign entity interest: To the extent that Kerecis realizes any benefit from legislative or executive action, so, too, would its parent company, Coloplast A/S.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURA FRIEDEL | — |
| JONATHAN JAGODA | — |
| Y. BRIAN LEE | — |
| JAMES PATRICK PALUSKIEWICZ | — |
| MARK RAYDER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.